Despite the progress has been reached with Human herpesvirus 8 (HHV-8) research, there are gaps in the knowledge of viral induced oncogenesis. The aim of the present study was to identify possible associations between HHV-8 subtypes, HHV-8 loads and clinical manifestations of HIV infected patients diagnosed with different malignancies associated with HHV-8 infection. Forty six HIV-1 infected individuals diagnosed with different HHV-8 associated diseases were studied [37 epidemic Kaposi's sarcoma (KS), 3 pleural effusion lymphoma (PEL); 5 peripheral lymphadenopathies (PL); 1 Hodgkin's lymphoma (HL); 1 non Hodgkin's lymphoma (NHL)]. HHV-8 loads were determined by quantitative real time PCR (qRT-PCR) whilst HHV-8 subtypes were determined by open-reading frame (ORF)-K1 gen genotyping. HHV-8 subtypes B, A, C, A5 and E were exhibited by 31.8%, 23.4%, 19.1%, 17% and 8.5% of the studied patients, respectively. The median HHV-8 viral load did not differ between subtypes (p > 0.05) but HHV-8 viral loads were significantly higher in PEL than in epidemic KS lesion or lymph nodes (p = 0.04). Subtype B was detected in 60% of patients with B cell lymphoma (NHL, PEL and HL) whereas subtype E was only detected in patients with epidemic KS diagnosis. Our data suggest that HHV-8 DNA quantification instead of subtype identification could be used as a surrogate marker for monitoring its infection, not only in epidemic KS patients but also in HIV infected individuals with lymphoproliferative disorders.
Introduction
HHV-8 also referred as Kaposi's Sarcoma-Associated Herpesvirus is the first known human Rhadinovirus which belongs to the Gammaherpesvirinae subfamily, Herpesviridae family. It is implicated as the causative agent of all clinical forms of Kaposi's Sarcoma (classical, epidemic, endemic and iatrogenic), PEL and multicentric Castleman's disease (MCD) [1] but its role in other lymphoproliferative disorders has not been clearly established. Although the HHV-8 genome is highly conserved along most of the unique coding region (approx. 145 kbp), several genomic regions display remarkable sequence variability making them useful markers of strain diversity and potential epidemiologic patterns of HHV-8 spread. Five major subtypes are recognized by K1 genotyping: A, B, C, D and E. The K1 protein is highly variable in its cysteine-rich N-terminal ectodomain and its amino acid sequence has been shown to vary by up to 40%, with changes concentrated in two hypervariable regions (VR1 and VR2) [2] .
The influence of particular subtypes on disease progression remains largely unknown. Therefore, it is importent to identify biological markers related with HHV-8-associated diseases outcome. Some authors have alerted that the risk of KS remains substantially increased in HIV infected subjects and further decreases have not been observed [3] ; being KS recently diagnosed in patients with controlled HIV infection and CD4 counts over 200 T cells [4] . Epidemic KS incidence has not been significantly reduced in Cuba although locally produced antiretroviral drugs started being introduced as a form of treatment since 2001. Previous studies have shown that, with the exception of subtype D, the majority of HHV-8 subtypes were circulating among Cuban HIV population [5, 6] . However, a change in HHV-8 subtype distribution was recently identified with an increase in subtype B detection [7] . Thus, we decided to identify how viral factors (K1 subtype and viral load) may impact on the oncogenesis induced by HHV-8 among HIV infected individuals diagnosed with different malignancies.
Materials and Methods

Patients and Samples
The study was approved by local and national ethics committees. All participants provided their written informed consent to participate in the study. Forty six HIV-1 infected individual diagnosed with HHV-8 associated diseases between 2005 and 2011 inclusive were included and different samples were collected ( Table 1) . One patient contributed with two samples since KS in the lymph node was diagnosed six month after the initial diagnosis of PEL in the pericardium. The diagnosis of vasoproliferative lesion of the lymph node and the AIDS-related complex lymphadenitis were based on the histopathological diagnosis as described elsewhere [8] . Clinical, immunological and epidemiological data from each patient were obtained throughout a retrospective review of individual's clinical records and are depicted in Table 2 .
Sampling and DNA Extraction
DNA was extracted from frozen tissues samples by QIAamp ® DNA Mini Kit (QIAGEN, Germany), according to the protocol for DNA purification from tissues described by the manufacturer. In contrast, 200 µL of the effusion fluid from PEL patients and the sample of saliva obtained from the patient diagnosed with Hodgkin lymphoma were used to purify DNA using the same kit but following the protocol for blood or body fluids. Genomic DNA (gDNA) concentration was determined by spectrophotometer (GeneQuant II, Pharmacia Biotech, USA) and adjusted to 100 ng (10 µL).
qRT-PCR for HHV-8 DNA Quantification
An "in-house" Taqman methodology based qRT-PCR was used for HHV-8 quantification in clinical samples. The protocol conditions, primers and probe were described by Watzinger et al. [9] with minor modifications adapted for the LightCycler 1.5 [10] . The HHV-8 loads were expressed as copies/100 ng of DNA. Human  globin was amplified by Real Time PCR using primers, probes and the protocol previously described elsewhere [11] .
DNA Sequencing of HHV-8 ORF K1
A fragment of ORF-K1 gen was amplified by nested PCR from the assayed samples following the protocol published elsewhere [2] . PCR products from nested PCR were purified using MiniEluteTM Purification Kit (QIAGEN, Germany) following the manufacturer's protocol and their final concentration were evaluated throughout horizontal electrophoresis in 2% agarose gel stained with ethidium bromide (0.5 μg/mL) and visualized through a UV transilluminator.
The Kit Dye labeled dideoxy Terminator Cycle Sequencing from Beckman Coulter (USA) was used for nucleotide sequence analysis, following the manufacturer recommendations. One hundred fentomoles of PCR products were added to a mixture containing 1 µl (5 pmol) of either forward or reverse primer (LGH2090 and LGH2508), 8 µl of sequence reaction mixture (DTCS Quick Star Master Mix) and water up to a final volume of 20 µl. The sequencing reaction was conducted by 50 cycles of two minutes at 96˚C for 20 seconds, 50˚C for 20 seconds and finally 60˚C for 4 minutes. The obtained fragments were purified following the manufacturer instructions. Finally, the purified products underwent electrophoresis on a Beckman Coulter CEQ8800 sequencer.
Sequence Analysis
Initial evaluation of each sequence was performed using the nucleotide search engine BLAST at NCBI (USA), to confirm that the amplified product was K1. Then, nucleotide sequences were manually edited with both forward and reverse primers using MEGA version 4 [12] . To determine the K1 subtype of each subject's strain(s), nucleotide sequences were aligned by Muscle in Jalview version 2.4 [13] along with the following reference strains obtained from Genetic sequence database (Gen-Bank) at the National Center for Biotechnology Information (NCBI) [AF133038 (A1); AF130305 (A2); U86667 (A3); AF133039 (A4); AF178823 (A5); AF133040 (B1); AF130259 (B2); AF133041 (C1); AF133042 (C3); AF133043 (D1) AF133044 (D2); AF220292 (E)].
Maximum likelihood (ML) trees were estimated using PAUP 4.0 beta under the best-fit substitution model calculated by Modeltest 3.7 [14] using the Akaike information criterion. New HHV-8 nucleotide sequences and the derived aminoacid (aa) sequences were deposited in GenBank using the National Center for Biotechnology Information (Bethesda, MD). Throughout Sequin Application version 11.0. The GenBank accession numbers for 46 new sequences obtained in this manuscript are: FJ986113 to FJ986144, GU475457 to GU475460, JF979530, JF979532 to JF979543.
Statistical Methods
IBM SPSS Statistics package version 19 and Epidat version 3.1 were used to process all the data. ANOVA test was performed in order to compare the values of HHV-8 loads among identified subtypes, histopathological diagnosis and different compartments in which the tumor arise. Contingency tables were constructed and Chisquare test or Fisher's exact test were used for comparing data. Odds ratios (OR) and their 95% confidence intervals (CI) were used to assess the association between variables. HHV-8 sequences obtained from the same individual were included separately for statistical analysis since they were amplified at different times from different diseases. The value of HHV-8 loads in saliva from the patient diagnosed with HL was not included in the analysis.
Results
The phylogenetic characterization allowed the identification of different HHV-8 subtypes among the studied individuals (Figure 1) . HHV-8 subtypes B, A, C, A5 and E were exhibited by 31.8%, 23.4%, 19.1%, 17% and 8.5% of the studied patients, respectively. Overall, no statistical associations were discovered between HHV-8 subtypes and the following variables: CD4+ T cell counts, HIV-1 loads, sex and age (p > 0.05). There were no significant differences in subtypes frequencies among HHV-8 associated diseases (p > 0.05) ( Table 3) . No statistical differences were found among K1 subtypes when the median elapsed time between HIV diagnosis and HHV-8 associated diseases appearance were compared (p = 0.444). Nevertheless, individuals infected with subtype E and A5 seem to progress slower to HHV-8 associated diseases than individuals infected by subtypes A, B or C. No differences were detected between the median copy number of each identified HHV-8 subtypes irrespective the histhopathological diagnosis (p > 0.05) (Figure 2) . However, the median HHV-8 viral load was significantly higher in PEL than in epidemic KS lesion or lymph nodes (p = 0.04) (Figure 3) .
Epidemic KS
Patients diagnosed with epidemic KS showed a wide range of subtypes although strains belonged to subtype E were only identified in the tissue of these patients ( Table  3) . Nodular stage of epidemic KS were identified in 12/37 (patients 32.4%) whilst 8/37 (21.6%) and 2/37 (5.4%) were considered to be in macular and patch stage; respectively. No associations were identified between the histological stages, HHV-8-subtypes and their DNA copy number in the affected tissue (p > 0.05). However, 15 of 37 obtained biopsies (40.5%) were not classified by histopathological analysis.
B Cell Lymphoma
Subtype B was detected in 3/5 studied patients diagnosed with B cell lymphoma (NHL, PEL and HL) but PEL patients exhibited different HHV-8 subtypes ( Table 3) . EBV DNA was also detected in all the studied effusion fluid by qRT-PCR (data not shown). Subtype B (58LN/ 2009) was detected in an HIV infected patient diagnosed with NHL of immunoblastic subtype which had no prior history of KS but he was markedly immunosuppressed (CD4+ T cell count 112 cells/mm 3 ). In contrast, Cub 59S/09 (subtype B) was isolated from a mixed cellular subtype of a Hodgkin lymphoma patient's saliva. Although HHV-8 DNA was not amplified in the lymph node 22,980 copies/100 ng of DNA were found in saliva by qRT-PCR Higher EBV DNA copies number was also quantified in the saliva and lymph node collected both from NHL and Hodgkin lymphoma patients (data not shown).
Peripheral Lymphadenopathies
Different subtypes were exhibited by patients diagnosed with peripheral lymphadenopathies (Table 3) . No history of KS lesions on the skin or mucous surface neither on chest X-rays, abdominal scan and upper digestive tract endoscopy revealed signs of visceral KS. Patients diagnosed with AIDS-related complex lymphadenitis exhibited subtype A5 and they showed an enlargement of the lymph node as the only clinical sign (1T/2009: cervical area; Cub-62LN/2009: axillary area). HIV-1 infection was diagnosed few months the beginning of lymph node swollen. They had a CD4 T cells counts over 200 cells whilst their HIV-1 loads were 27,000 and 30 copies/mL; respectively. The detected copy numbers of HHV-8 DNA in the lymph node were 79 and 495 copies/100 ng of gDNA, respectively. Subtypes A5 were significantly associated with the diagnosis of AIDS-related complex lymphadenitis (p = 0.0271).
KS was diagnosed in two lymph nodes fragments of the studied HIV-1 infected individuals. The first one exhibited subtype C (50T/2009) which was identified in the lymph node of patient who complained of a swollen of the cervical area with no other symptoms at the time by which KS diagnosis was made. He had a previous history of a PEL at the pericardium (Cub-296/09). Both aa sequences grouped in the same branch of the tree (p = 0.032) (Figure 1 ) however visual comparison of the alignment showed specific changes (50T/2009: G191A, L197S, L213I, P254H). His CD4 T cell count was 142 cells/mm 3 and the copy number of HHV-8 DNA in the lymph node was 215,100 copies/100 ng of gDNA. The second individual in whom KS was diagnosed resulted to be infected by subtype B (17T/2009) and complained a localized enlargement of lymph nodes in the inguinal area, accompanied by fever. His CD4+ T cell count was 300 cells/mm 3 and the HIV-1 viral load was 14,000 copies/mL. The determined value of HHV-8 DNA in the lymph node was 3,300,000 copies/100 ng of gDNA.
The vasoproliferative lesion of the lymph node was diagnosed in an AIDS rapid progressor admitted due to a three month history of fever, weight loss, cervical mass, fatigue and dyspnea. On the physical examination a remarkable paleness of the mucous surface and skin were noted, accompanied by spleen enlargement. Laboratory examination showed severe anemia (4.5 g/L) and increased erythrocyte sedimentation rate (130 mm). The patient was severe immune depressed (CD4 T cell count: 163 cells/mm 3 ) and the HIV-1 viral load was 160,000 copies/mL. Hepatomegaly and splenomegaly were found on the abdominal scan. Subtype A (32T/2009) was identified by nucleotide sequence analysis with a total amount of 900,000 copies/100 ng of gDNA in the lymph node.
Discussion
Although some authors have pointed that viral factors are not likely to play an important role in HHV-8 oncogenesis [15] , the available evidence is not conclusive and they need to be explored thoroughly. So far, differences in the replication rates by HHV-8 subtypes have not been reported. The possible impact of HHV-8 subtypes and their viral load in disease pathogenesis have been difficult to evaluate before. Perhaps, the low incidence of HHV-8 associated diseases in populations at risk and also the restricted geographical subtype's distribution have confined its assessment. Present findings suggest that HHV-8 oncogenicity is not related to specific subtype demonstrating that there are not differences between their replicative capacities.
In contrast, it was known that HHV-8 viral loads in affected tissue should be considered as an important marker for monitoring its infection. In agreement with others [16] [17] [18] , the obtained data highlight that HHV-8 load varied among anatomic sites and it would be related with the histhopathological diagnosis being higher in PEL. Those findings support the usefulness of qRT-PCR in HHV-8 diagnosis and underline the existence of not well defined viral characteristic that allows HHV-8 maintenance, replication and also its capacity to transform target cells into a malignant one among different neoplasms [19] . Unfortunately, those mechanisms are not well understood yet.
Interestingly, like the previous report from Cassar and colleagues [20] , Cuban E subtypes were detected in epidemic KS lesions whereas it seems to be rarely associated with KS in Brazilian Amerindians [21] . Thus, it would indicate that the Cuban subtype E has evolved to a more invasive variant which can transform endothelial cells or maybe the lower frequency of Amerindian's alleles among Cuban population [22] has predisposed the appearance of KS, not only the epidemic but also the classical variant [23] .
The development of a variety of lymphoproliferative disorders due to B cells infection by HHV-8 have been previously reported by others [24] . Nevertheless, it was not previously demonstrated in Cuba. Present data have expanded the spectrum of HHV-8 associated diseases among HIV population; maybe, the role of HHV-8 in malignant lymphoproliferation was underestimated before. It reveals the significance of HHV-8 diagnosis for the management of those malignancies arising in HIV population which may be predominantly caused by subtype B. Now, there is a controversy around the participation of HHV-8 in NHL. In this sense, some authors have also agreed that HHV-8 DNA detection in the lymph node would be considered not only as opportunistic infection but also as an agent involved in malignant lymphoproliferation [25] . Furthermore, rare HHV-8 positive solid lymphomas have been described as extra-cavitary PELs forms [26] and Engels and colleagues have previously reported a similar case of NHL from Ugandan pediatric patient [27] . On the other hand, it is possible that HHV-8 may be shed in saliva from HIV infected patient diagnosed with Hodgkin lymphoma, its role in this malignancy has not been established before. Accordingly, it has to be pointed that the number of studied patients with lymphoma diagnosis is limited. Therefore, the participation of HHV-8 in lymphoproliferative disorders will need to be established in the future.
The studied PEL cases were the first to be diagnosed since the beginning of Cuban AIDS epidemic in 1986. At present, it is revealed that PEL can be caused by different HHV-8 subtypes. In addition, the K1 amino acid changes that were identified in the strain isolated from the same individual are in agreement with the results obtained by Lacoste and colleagues [28] . However, others have obtained contrasting results [29] suggesting that K1 variation did not occur over the lifetime of a single infected host. Even though ORF-K1 mutation rates were identified to be similar to genes in other human pathogens [e.g. gen env from HIV-1 [2] , there are neither evidences of error-prone replication mechanism that would permit HHV-8 positive selection not specialized mechanisms to rapidly generate a high level of diversity [30] . The causes of this extreme variability are not well understood but host immune pressure seems to be one of the possible explanations. However, the effects of Taq polymerase error prone during PCR amplification would not be definitely excluded.
The clinical characteristic of HHV-8 primary infection has not been well defined. The first report was done by Oksenhendler and colleagues in an HIV subject [31] and it has been latter described in renal and bone marrow transplant recipients [32, 33] as in children from Egypt and Africa [34, 35] . Conversely, its occurrence has been difficult to prove since previous serological status is difficult to establish. HHV-8 DNA detection at lymph node fragments obtained from Cuban patients diagnosed with AIDS-related complex lymphadenopathy and vasoproliferative lesion of the lymph node would be indicative of its primary infection, since neither signs nor symptoms of KS or other HHV-8 associated diseases were identified. Unfortunately, the seroconversion to HHV-8 was impossible to identify since no serum samples collected before the onset of symptoms were available. Thus, it would be impossible to arrive to this diagnosis in the Cuban studied patients. However, a closer follow up was recommended to clinicians since those individuals were recognized at risk of developing malignancies associated with this Gammaherpesvirus. The association between subtype A5 with AIDS-related complex lymphadenitis as a form of HHV-8 primary infection will need to be elucidated in the future since a small number of patients were included.
Overall, our findings suggest that although different HHV-8 subtypes circulate among Cuban HIV-1 population, it is not necessary to determine the infecting subtype for their clinical management. In contrast, HHV-8 viral load could be used as a surrogate marker for monitoring its infection, not only in epidemic KS patients but also in those diagnosed with different lymphoproliferative disorders. Moreover, it was elucidated that the spectrum of HHV-8 associated diseases has expanded among Cuban HIV population irrespective the K1 subtypes. Others host factors will need to be explored in the future if HHV-8 transmission would need to be limited among Cuban HIV population.
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